theme,sub_theme,topic,geography_type,geography,metric,sex,age,stratum,year,date,metric_value,in_reporting_delay_period
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-08-01,5.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-08-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-08-01,20.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-08-01,45.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-08-01,11.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-08-01,14.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-08-01,17.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-07-01,2.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-07-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-07-01,18.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-07-01,45.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-07-01,10.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-07-01,14.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-07-01,15.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-06-01,3.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-06-01,0.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-06-01,20.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-06-01,46.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-06-01,10.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-06-01,12.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-06-01,17.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-05-01,3.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-05-01,0.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-05-01,18.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-05-01,47.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-05-01,10.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-05-01,11.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-05-01,17.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-04-01,3.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-04-01,0.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-04-01,19.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-04-01,48.8300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-04-01,11.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-04-01,10.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-04-01,17.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-03-01,3.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-03-01,0.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-03-01,18.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-03-01,48.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-03-01,11.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-03-01,11.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-03-01,15.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-02-01,6.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-02-01,0.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-02-01,19.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-02-01,46.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-02-01,11.7400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-02-01,13.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-02-01,15.7200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2025,2025-01-01,7.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2025,2025-01-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2025,2025-01-01,19.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2025,2025-01-01,46.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2025,2025-01-01,10.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2025,2025-01-01,14.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2025,2025-01-01,16.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-12-01,5.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-12-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-12-01,17.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-12-01,48.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-12-01,11.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-12-01,13.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-12-01,18.6200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-11-01,3.2800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-11-01,0.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-11-01,17.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-11-01,50.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-11-01,10.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-11-01,12.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-11-01,17.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-10-01,1.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-10-01,0.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-10-01,16.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-10-01,51.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-10-01,9.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-10-01,11.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-10-01,17.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-09-01,1.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-09-01,0.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-09-01,16.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-09-01,49.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-09-01,8.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-09-01,10.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-09-01,15.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-08-01,2.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-08-01,0.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-08-01,17.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-08-01,45.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-08-01,9.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-08-01,11.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-08-01,15.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-07-01,5.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-07-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-07-01,17.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-07-01,41.3700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-07-01,9.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-07-01,11.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-07-01,14.5500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-06-01,5.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-06-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-06-01,18.9500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-06-01,38.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-06-01,10.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-06-01,12.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-06-01,14.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-05-01,4.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-05-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-05-01,18.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-05-01,40.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-05-01,10.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-05-01,11.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-05-01,16.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-04-01,4.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-04-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-04-01,18.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-04-01,42.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-04-01,10.1500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-04-01,11.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-04-01,16.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-03-01,4.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-03-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-03-01,17.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-03-01,41.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-03-01,8.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-03-01,10.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-03-01,16.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-02-01,4.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-02-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-02-01,17.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-02-01,44.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-02-01,8.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-02-01,11.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-02-01,15.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2024,2024-01-01,4.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2024,2024-01-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2024,2024-01-01,18.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2024,2024-01-01,44.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2024,2024-01-01,8.9300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2024,2024-01-01,11.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2024,2024-01-01,15.6400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-12-01,6.3800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-12-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-12-01,18.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-12-01,46.5400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-12-01,9.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-12-01,11.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-12-01,16.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-11-01,5.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-11-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-11-01,17.6800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-11-01,42.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-11-01,9.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-11-01,11.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-11-01,15.4300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-10-01,2.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-10-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-10-01,17.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-10-01,40.9100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-10-01,9.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-10-01,11.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-10-01,14.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-09-01,1.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-09-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-09-01,19.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-09-01,40.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-09-01,10.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-09-01,10.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-09-01,15.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-08-01,1.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-08-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-08-01,19.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-08-01,43.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-08-01,10.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-08-01,10.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-08-01,14.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-07-01,2.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-07-01,0.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-07-01,19.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-07-01,43.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-07-01,9.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-07-01,11.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-07-01,15.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-06-01,2.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-06-01,0.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-06-01,19.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-06-01,43.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-06-01,8.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-06-01,12.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-06-01,15.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-05-01,3.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-05-01,0.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-05-01,19.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-05-01,43.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-05-01,7.8900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-05-01,12.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-05-01,16.0200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-04-01,4.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-04-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-04-01,19.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-04-01,46.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-04-01,9.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-04-01,11.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-04-01,15.8100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-03-01,3.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-03-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-03-01,17.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-03-01,47.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-03-01,8.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-03-01,12.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-03-01,15.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-02-01,2.3600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-02-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-02-01,16.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-02-01,46.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-02-01,7.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-02-01,12.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-02-01,15.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2023,2023-01-01,1.6700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2023,2023-01-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2023,2023-01-01,16.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2023,2023-01-01,45.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2023,2023-01-01,7.7600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2023,2023-01-01,11.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2023,2023-01-01,15.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-12-01,2.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-12-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-12-01,16.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-12-01,43.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-12-01,8.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-12-01,9.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-12-01,15.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-11-01,2.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-11-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-11-01,16.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-11-01,41.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-11-01,9.2000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-11-01,8.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-11-01,14.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-10-01,1.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-10-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-10-01,16.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-10-01,40.6500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-10-01,10.0300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-10-01,9.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-10-01,14.5200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-09-01,2.0400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-09-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-09-01,17.1300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-09-01,39.4800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-09-01,9.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-09-01,9.8700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-09-01,14.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-08-01,4.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-08-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-08-01,15.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-08-01,42.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-08-01,10.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-08-01,10.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-08-01,15.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-07-01,6.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-07-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-07-01,15.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-07-01,40.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-07-01,8.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-07-01,9.8200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-07-01,14.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-06-01,5.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-06-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-06-01,14.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-06-01,40.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-06-01,7.4900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-06-01,9.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-06-01,14.1600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-05-01,3.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-05-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-05-01,14.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-05-01,38.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-05-01,6.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-05-01,9.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-05-01,12.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-04-01,2.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-04-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-04-01,12.7800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-04-01,40.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-04-01,6.9200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-04-01,9.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-04-01,11.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-03-01,3.5000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-03-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-03-01,14.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-03-01,40.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-03-01,8.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-03-01,9.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-03-01,11.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-02-01,4.2900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-02-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-02-01,15.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-02-01,42.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-02-01,8.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-02-01,8.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-02-01,11.7300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2022,2022-01-01,4.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2022,2022-01-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2022,2022-01-01,16.7900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2022,2022-01-01,42.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2022,2022-01-01,8.8600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2022,2022-01-01,9.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2022,2022-01-01,13.4200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-12-01,5.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-12-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-12-01,16.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-12-01,44.2400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-12-01,8.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-12-01,10.0700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-12-01,13.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-11-01,4.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-11-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-11-01,16.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-11-01,43.3900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-11-01,8.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-11-01,9.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-11-01,14.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-10-01,4.2600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-10-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-10-01,16.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-10-01,42.1900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-10-01,7.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-10-01,9.6000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-10-01,13.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-09-01,3.6600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-09-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-09-01,15.8500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-09-01,42.0600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-09-01,8.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-09-01,9.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-09-01,13.8000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-08-01,2.9700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-08-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-08-01,15.4500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-08-01,43.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-08-01,7.0800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-08-01,9.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-08-01,13.4700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-07-01,1.5100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-07-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-07-01,14.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-07-01,42.2100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-07-01,7.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-07-01,8.0900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-07-01,13.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-06-01,1.5900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-06-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-06-01,13.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-06-01,41.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-06-01,6.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-06-01,7.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-06-01,12.7100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-05-01,2.2200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-05-01,0.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-05-01,13.9800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-05-01,42.1400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-05-01,7.2500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-05-01,7.3400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-05-01,12.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-04-01,3.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-04-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-04-01,15.1000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-04-01,42.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-04-01,7.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-04-01,7.5300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-04-01,14.5600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-03-01,1.9900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-03-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-03-01,15.3100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-03-01,41.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-03-01,7.2700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-03-01,5.6300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-03-01,13.9000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-02-01,2.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-02-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-02-01,15.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-02-01,39.5700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-02-01,6.3300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-02-01,4.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-02-01,12.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2021,2021-01-01,1.4600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2021,2021-01-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2021,2021-01-01,14.9400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2021,2021-01-01,40.7500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2021,2021-01-01,5.8800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2021,2021-01-01,4.5800,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2021,2021-01-01,10.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-12-01,3.0100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-12-01,0.0000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-12-01,15.8400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-12-01,42.6900,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-12-01,6.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-12-01,5.7000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-12-01,12.6100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-11-01,2.1700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-11-01,0.1200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-11-01,16.4000,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-11-01,43.3200,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-11-01,7.3500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-11-01,5.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-11-01,12.4100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Amikacin,2020,2020-10-01,2.0500,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Carbapenems,2020,2020-10-01,0.1100,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Ciprofloxacin,2020,2020-10-01,16.4400,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Co-amoxiclav,2020,2020-10-01,41.9600,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Gentamicin,2020,2020-10-01,7.7700,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Piperacillin with tazobactam,2020,2020-10-01,5.2300,False
infectious_disease,antimicrobial_resistance,E-coli,UKHSA Region,Yorkshire and Humber,e-coli_testing_bacteraemiaPercentResistantRollingMonth,all,all,Third Generation Cephalosporins,2020,2020-10-01,12.5400,False
